FundedIQ
Health Care

SpineGuard

SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only devices with built-in DSG capability to improve the accuracy of pedicle screw placement. The PediGuard probes are handheld tools used by spine surgeons to perform pilot holes in the vertebrae before pedicle screw placement. An electrical conductivity measurement sensor, located at the tip of the drilling instruments, alerts the surgeon in real time and without using X-Ray imaging, about changes in conductivity that occur at the transition between cancellous bone, cortical bone and soft tissues/ blood. These devices are used in surgeries for all kind of patients, from pediatric in deformity corrections to adult in degenerative diseases requiring internal fixation. The PediGuard devices are available in different diameters and shapes (straight, curved, cannulated and Threaded). Our new product, The DSG® Connect App, allows collection and visualization on a tab of the signal measured at the tip of DSG Connect devices during pedicle drilling. These medical devices have assisted spine surgeons in accurately placing pedicle screws in over 80,000 spinal procedures around the world. With mounting clinical evidence (16 major Peer-Reviewed publications) confirming its efficacy, PediGuard devices are becoming a compelling answer to the clinical needs associated with safe and accurate pedicle screw placement.

www.spineguard.com Vincennes, France 11-50 employees
Total raised
$540k
Rounds
1
Latest
Series Unknown
May 2023

SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only devices with built-in DSG capability to improve the accuracy of pedicle screw placement. The PediGuard probes are handheld tools used by spine surgeons to perform pilot holes in the vertebrae before pedicle screw placement. An electrical conductivity measurement sensor, located at the tip of the drilling instruments, alerts the surgeon in real time and without using X-Ray imaging, about changes in conductivity that occur at the transition between cancellous bone, cortical bone and soft tissues/ blood. These devices are used in surgeries for all kind of patients, from pediatric in deformity corrections to adult in degenerative diseases requiring internal fixation. The PediGuard devices are available in different diameters and shapes (straight, curved, cannulated and Threaded). Our new product, The DSG® Connect App, allows collection and visualization on a tab of the signal measured at the tip of DSG Connect devices during pedicle drilling. These medical devices have assisted spine surgeons in accurately placing pedicle screws in over 80,000 spinal procedures around the world. With mounting clinical evidence (16 major Peer-Reviewed publications) confirming its efficacy, PediGuard devices are becoming a compelling answer to the clinical needs associated with safe and accurate pedicle screw placement.

SpineGuard has raised $540k across 1 round. Its most recent round was a Series Unknown of $540k in May 2023. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
May 16, 2023
Series Unknown
$540k

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

SpineGuard is featured in

Similar companies

Dillico

Dillico is a tech company focusing on creating innovative machinery to make the production of mRNA vaccines and medicines more efficient and accessible worldwide.

Seed $8.8M
Parallel 1245

Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate medical coding.

Seed $3.5M
Fizimed
Series Unknown $4.3M
Circle Safe

Atrial fibrillation is the leading heart rhythm disorder. The best method to avoid it coming back is by undergoing an intervention called ablation. Ablation can be done using Radiofrequency or Cryoballoon, with the latter being a newer, quicker, and simpler technique. However, Cryoballoon ablation carries the risk of causing Diaphragmatic Paralysis. Circle Safe is working on a solution to eradicate this complication entirely.

Series Unknown $8.3M
Lyv

Lyv assists individuals who are experiencing suffering.

Seed $2.7M
Median Technologies

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.

Series Unknown $39.3M
Kwit

Kwit creates scientific methods for quitting smoking and provides daily support with positivity and compassion.

Series Unknown $360k
Robeaute

Robeaute is a research and development agency that creates neurosurgical microrobots capable of adjusting to various forms of medical data.

Series A $28.0M
BiPER Therapeutics

A first-in-class pipeline of small compounds aimed at the cancer's overall metabolism is being created by BiPER Therapeutics. The company's main substance, BPR001, is a first-in-class small molecule therapy that targets the oncogenic protein BiP, which has been proven to play a significant role in cancer through the control of endoplasmic reticulum stress.

Series Unknown $840k
CILcare

CILcare specializes in providing drug solutions for hearing and ear disorders.

Series A $22.1M
Jinko

Jinko offers personalized supportive assistance to individuals affected by cancer.

Seed $1.6M
Moria

Moria creates, produces, and sells ophthalmic surgery equipment and instruments for refractive and reconstructive procedures.

Series Unknown $38.8M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.